BACKGROUND AND OBJECTIVES
Fibroblast growth factor 23 (FGF23) is an independent risk factor for mortality in patients with ESRD. Before FGF23 testing can be integrated into clinical practice of ESRD, further understanding of its determinants is needed.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS
In a study of 67 adults undergoing peritoneal dialysis, we… (More)